Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Trump's Budget Request To Include ANDA Exclusivity Changes

Feb 11 2018

• By Derrick Gingery

Clock

Related Content

Groundhog Day For HHS And Drug Pricing? Why It Might Be Different This Time

Feb 07 2018

Trump Emphasizes Foreign Drug Prices At Alex Azar's Swearing In

Jan 30 2018

Pay-For-Delay, REMS Reform Legislation Making (Slow) Progress In House

Jul 28 2017

Trump's Budget Outline Threatens User Fee Agreements

Mar 17 2017

US FDA Gives Directions On Navigating Generic 180-Day Exclusivity Maze

Jan 26 2017

CMS 2012 Budget Looks To Biosimilars, Brand/Generic Deals To Offset Costs

Feb 21 2011

Gottlieb Places Drug Pricing Out Front In First Speech To US FDA Staff

May 16 2017

New ANDA Review Pathways: Should You Be A Priority Or Expedited?

Nov 13 2017

Additional Topics

United States FDA Generic Drugs Regulation Legal Issues BioPharmaceutical

More from US FDA

More from Agency Leadership

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window